PMID: 42487237

Metabolic and Glycemic Effects of Orforglipron, a GLP-1 Receptor Agonist, in Adults With or Without Diabetes: A Network Meta-Analysis of Randomised Clinical Trials.

Hageen Ahmed W, Gadelmawla Ahmed Farid, Saleh Ahmad Omar, Mohamed Mohamed Reyad, Abdallfatah Abdallfatah, Elsekhary Ahmed, El-Nemr Amira Fahmy, Eladawi Safir, Maihoub Odai, Abdulhay Hind

Endocrinology, diabetes & metabolism · 2026

Vol. 9, Issue 4, pp. e70275

View on PubMed DOI

This entry links to third-party literature. For research use only.

HumansDiabetes Mellitus, Type 2Glucagon-Like Peptide-1 Receptor AgonistsRandomized Controlled Trials as TopicBlood GlucoseHypoglycemic AgentsAdultGlycated HemoglobinWeight LossBody Weight

For research use only. This index links to third-party literature. Nothing here constitutes medical advice.